News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Videos|November 29, 2022

A glimpse into sentinel lymph node mapping

Author(s)Morgan Ebert, Managing Editor

Sarah Crafton, MD, details how sentinel lymph node mapping can help identify the stage of uterine cancers and lead to better patient care.

Sarah Crafton, MD, gynecologic oncologist at Allegheny Health Network in Pittsburgh, Pennsylvania, details how sentinel lymph node mapping can help identify the stage of uterine cancers and lead to better patient care.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

Early biopsy may improve endometrial cancer detection among symptomatic Black women | Image Credit: © luchschenF - © luchschenF - stock.adobe.com.

Early biopsy may improve endometrial cancer detection among symptomatic Black women

ByContemporary OB/GYN Staff

October 9th 2025

Cervical cancer linked to increased anal cancer risk | Image Credit: © Africa Studio - © Africa Studio - stock.adobe.com.

Cervical cancer linked to increased anal cancer risk

ByCeleste Krewson, Assistant Editor

September 11th 2025

Jesus Gonzalez Bosquet, MD, PhD, highlights test for earlier ovarian cancer detection | Image Credit: obgyn.medicine.uiowa.edu.

Jesus Gonzalez Bosquet, MD, PhD, highlights test for earlier ovarian cancer detection

ByJesus Gonzalez Bosquet, MD, PhD

September 9th 2025

Lower cervical cancer screening rates linked to higher late-stage diagnoses and mortality | Image Credit: © Parilov - stock.adobe.com.

Lower cervical cancer screening rates linked to higher late-stage diagnoses and mortality

ByMorgan Ebert, Managing Editor

August 15th 2025

Benefits found for self-collected cervical cancer screening | Image Credit: © SewcreamStudio - © SewcreamStudio - stock.adobe.com.

Benefits found for self-collected cervical cancer screening

ByCeleste Krewson, Assistant Editor

May 27th 2025

Latest CME

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

Raj Chovatiya, MD, PhD, MSCI, FAAD; Michael Rubio, PA-C, MMSc

Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances

Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances

Kathleen N. Moore, MD, MS, FASCO; Susana Banerjee, MBBS, MA, FRCP, PhD; David M. O’Malley, MD; Ritu Salani, MD, MBA

Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer

Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer

Kathleen N. Moore, MD, MS, FASCO; David M. O’Malley, MD

Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care

Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care

Kathleen N. Moore, MD, MS, FASCO; Ritu Salani, MD, MBA

Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials

Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials

Kathleen N. Moore, MD, MS, FASCO; Prof Susana Banerjee, MBBS, MA, FRCP, PhD

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

John Brandsema, MD; Neelam Goyal, MD

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Rachel N. Grisham, MD; Domenica Lorusso, MD, PhD

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Rebecca Shatsky, MD; Kelly McCann, MD, PhD; Michelle L. Taylor, ANP-BC

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Jill Alldredge, MD; Emely Alfaro, MS, RN, CNS, OCN

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Emely Alfaro, MS, RN, CNS, OCN; Jill Alldredge, MD

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

Trending on Contemporary OB/GYN

FDA initiates removal of boxed warnings, requests updated labeling for menopausal hormone therapy

Sage Wyatt, PhD, discusses cardiovascular risk assessment through HDP

Significant barriers to cardiac rehabilitation reported in women

Study reveals implantation and live birth rates for segmental aneuploids

© 2025 MJH Life Sciences^®

All rights reserved.